26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

consensus sequence 193 contact sensitivity (CS) or allergic contact dermatitis<br />

consensus sequence<br />

The typical nucleic acid or protein sequence where a nucleotide<br />

or amino acid residue present at each position is that<br />

found most often during comparison of numerous similar<br />

sequences in a specific molecular region.<br />

constant domain<br />

The immunoglobulin C H and C L regions encoded by the corresponding<br />

constant exon. There is only minor variability in the<br />

amino acid content of constant domains. A globular compact<br />

structure that consists of two antiparallel twisted β sheets.<br />

There are differences in the number and the irregularity of the<br />

β strands and bilayers in variable (V) and constant (C) subunits<br />

of immunoglobulins. C domains have tertiary structures that<br />

closely resemble those of the domains comprised of a fivestrand<br />

β sheet and a four-strand β sheet packed facing one<br />

another. However, the C domain does not have a hairpin loop<br />

at the edge of one of the sheets. Thus, the C domain has seven<br />

or eight β strands rather than the nine that are found in the V<br />

domains. Refers also to the constituent domains or constant<br />

regions of T cell receptor polypeptides.<br />

constant exon<br />

An exon that encodes the C terminal part of either an<br />

immunoglobulin or a T cell receptor protein. The splicing<br />

of a C exon at the mRNA level to a rearranged variable (V)<br />

exon yields a transcript of a complete immunoglobulin or<br />

T cell receptor gene. C exons of the immunoglobulin heavy<br />

chain gene locus are comprised of sub-exons.<br />

constant region<br />

That part of an immunoglobulin polypeptide chain that has<br />

an invariant amino acid sequence among immunoglobulin<br />

chains belonging to the same isotype and allotype. There is a<br />

minimum of two and often three or four domains in the constant<br />

regions of immunoglobulin heavy polypeptide chains.<br />

The hinge region tail end piece (carboxyl terminal region)<br />

constitutes part of the constant region in selected classes of<br />

immunoglobulin. A few exons encode the constant region<br />

of an immunoglobulin heavy chain, and one exon encodes<br />

the constant region of an immunoglobulin light chain. The<br />

constant region is the location for the majority of isotypic<br />

and allotypic determinants. It is associated with a number of<br />

antibody functions. T cell receptor α, β, γ, and δ chains have<br />

constant regions coded for by three to four exons. Major histocompatibility<br />

complex (MHC) class I and II molecules also<br />

have segments that are constant regions in that they show little<br />

sequence variation from one allele to another. Refers also to<br />

the part of a T cell receptor polypeptide chain that does not<br />

vary in sequence among different clones and is not involved in<br />

antigen binding.<br />

constitutive defense system<br />

See innate or constitutive defense system.<br />

consumption test<br />

An assay in which antigen or antibody disappears from<br />

the reaction mixture as a result of its interaction with the<br />

homologous antibody or antigen. The result is ascertained<br />

by quantifying the amount of unreacted antigen or antibody<br />

remaining in the reaction system and comparing it with the<br />

quantity of that reagent that was originally present. The<br />

antiglobulin consumption test is an example.<br />

contact dermatitis<br />

A type IV, T lymphocyte-mediated hypersensitivity reaction<br />

of the delayed type that develops in response to an<br />

allergen applied to the skin.<br />

contact hypersensitivity reaction<br />

A type IV delayed-type hypersensitivity reaction in the<br />

skin characterized by a delayed-type hypersensitivity<br />

(cell-mediated) immune reaction produced by cytotoxic T<br />

lymphocytes invading the epidermis. It is often induced<br />

by applying a skin-sensitizing simple chemical such as<br />

dinitrochlorobenzene (DNCB) that acts as a hapten uniting<br />

with proteins in the skin, leading to the delayed-type hypersensitivity<br />

response mediated by CD4 + T cells. Although<br />

substances such as DNCB alone are not antigenic, they<br />

may combine with epidermal proteins that serve as carriers<br />

for these simple chemicals acting as haptens. Spongiosis,<br />

vesiculation, and pleuritis are present. Poison ivy hypersensitivity<br />

is a type of contact hypersensitivity attributable to<br />

T cell responses to the chemical antigen pentadecatechol<br />

in poison ivy leaves. Langerhans’ cells are leukocytes in<br />

the epidermis that present antigen to CD4 + T cells. They<br />

possess long dendritic processes that course among the<br />

epidermal cells, forming a network that is usually encountered<br />

by any organism or antigen that penetrates through<br />

the stratum corneum barrier. In addition to the cytoplasmic<br />

organelles (Birbeck granules), they have membrane antigens<br />

that include CD1a major histocompatibility complex<br />

(MHC) class II antigens and costimulatory molecules B7-1<br />

and B7-2. They also express adhesion molecules such as<br />

E-cadherin, ICAM-1, and LFA-1. The latter two are requisite<br />

for their migration to the regional nodes and interaction<br />

with T cells.<br />

contact sensitivity (CS) or allergic contact dermatitis<br />

A form of delayed-type hypersensitivity (DTH) reaction<br />

limited to the skin and consisting of eczematous changes.<br />

It follows sensitization by topical drugs, cosmetics, or other<br />

types of contact chemicals. The causative agents, usually<br />

simple, low-molecular-weight compounds (mostly aromatic<br />

molecules), behave as haptens. The development of<br />

sensitization depends on the penetrability of the agent and<br />

its ability to form covalent bonds with protein. Part of the<br />

sensitizing antigen molecule is thus represented by protein,<br />

usually the fibrous protein of the skin. Local skin conditions<br />

that alter local proteins, such as inflammation, stasis, and<br />

others, facilitate the development of CS, but some chemicals<br />

such as penicillin, picric acid, or sulfonamides are unable<br />

to conjugate to proteins. It is believed that in this case the<br />

degradation products of such chemicals have this property.<br />

CS may also be induced by hapten conjugates given by other<br />

routes in adjuvants. The actual immunogen in CS remains<br />

unidentified. CS may also have a toxic, nonimmunologic<br />

component, and frequently both toxic and sensitizing effects<br />

can be produced by the same compound. With exposure to<br />

industrial compounds, an initial period of increased sensitivity<br />

is followed by a gradual decrease in reactivity. This phenomenon<br />

is called hardening and may represent a process of<br />

spontaneous desensitization. The histologic changes in CS<br />

are characteristic. Vascular endothelial cells in skin lesions<br />

produce cytokine-regulated surface molecules such as IL-2.<br />

IL4 mRNA is strongly expressed in allergic contact dermatitis<br />

lesions. IFN-γ mRNA is the predominant cytokine in<br />

tuberculin reactions. IL10 mRNA overexpression in atopic<br />

dermatitis may facilitate upregulation of humoral responses<br />

and downregulation of T H1 responses. Selected allergic<br />

subjects manifest several types of autoantibodies including<br />

IgE and β-adrenergic receptor autoantibodies.<br />

C

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!